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Potential
Cell cytotoxin neutralisation is both highly sensitive and specific, however it is laborious and slow, therefore results cannot be provided in a clinically relevant timeframe. It would also not be possible to categorise patients into excretors or infected, nor to predict risk of severe infection using this method. For these reasons it is routinely used by few centres. (9)
Classifying symptomatic patients into infected and excretor status may be important in terms of infection prevention and control, since excretors are just as likely to contaminate the clinical environment with spores as those with infection. (3) As recommended by European guidelines (10) the use of GDH and toxin EIA is highly specific, resulting in a false positive rate of 0.4-0.6%, (7) however the estimated 95% confidence interval for sensitivity is 78.8-84.5%, resulting in a false negative rate of 15.5-21.2%.
Thus, although the use of PCR Ct values may be valuable in determining severity of infection, risk of recurrence and mortality, it is difficult to envisage that the use of a PCR alone would be sufficient test of true infection.
GDH (or PCR) followed by a toxin EIA remains the most optimal and practical method available today, however diagnostics manufacturers should be challenged to develop better performing tests which are rapid and both highly sensitive and specific. Receiver-operating curve (ROC) of tcdB cycle threshold (CT) values for detection of free toxin by enzyme immunoassay.
